1-4 of 4
Matthew P. Smeltzer, MStat
Close
Sort by
Journal Articles

High Failure Rate with Brigance Developmental Screening in 3 Year-Old Children with Sickle Cell Disease

Winfred C. Wang, MD, Molly Beth Freeman, MS, Yvonne M. Carroll, JD, RN, Latacha Hamilton, EdS, Matthew P. Smeltzer, MStat, PhD, Guolian Kang, PhD, Jane S. Hankins, MD MS, Banu Aygun, MD
Journal: Blood
Blood (2014) 124 (21): 4926.
https://doi.org/10.1182/blood.V124.21.4926.4926
Published: 2014
Journal Articles

Brain MRI/MRA Findings after Hydroxyurea Treatment in Children with Sickle Cell Anemia

Kerri Nottage, MD MPH, Russell E. Ware, MD PhD, Matthew P. Smeltzer, MStat, PhD, Jola Dowdy, MS, Winfred C. Wang, MD, Jane S. Hankins, MD MS, Kathleen J. Helton, MD, Banu Aygun, MD
Journal: Blood
Blood (2014) 124 (21): 89.
https://doi.org/10.1182/blood.V124.21.89.89
Published: 2014
Journal Articles

Higher Fetal Hemoglobin Following Escalation of Hydroxyurea to Maximum Tolerated Dose Provides Clinical Benefit to Children with Sickle Cell Anemia

Jeremie H. Estepp, MD, Matthew P. Smeltzer, MStat, PhD, Guolian Kang, PhD, Banu Aygun, MD, Russell E. Ware, MD, PhD, Kerri Nottage, MD MPH
Journal: Blood
Blood (2014) 124 (21): 85.
https://doi.org/10.1182/blood.V124.21.85.85
Published: 2014
Journal Articles

Escalating Doses Of Hydroxyurea In Very Young Children With Sickle Cell Anemia

Shangli Lian, MD, PhD, Jeremie H. Estepp, MD, Matthew P. Smeltzer, MStat, Winfred C. Wang, MD
Journal: Blood
Blood (2013) 122 (21): 978.
https://doi.org/10.1182/blood.V122.21.978.978
Published: 2013